BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37782699)

  • 1. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
    Quan J; Ma C
    Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT1-mediated epigenetic suppression of FBXO32 expression promoting cyclin dependent kinase 9 (CDK9) survival and esophageal cancer cell growth.
    Song XQ; Chen BB; Jin YM; Wang CY
    Cell Cycle; 2024 Feb; 23(3):262-278. PubMed ID: 38597826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
    Chou JL; Su HY; Chen LY; Liao YP; Hartman-Frey C; Lai YH; Yang HW; Deatherage DE; Kuo CT; Huang YW; Yan PS; Hsiao SH; Tai CK; Lin HJ; Davuluri RV; Chao TK; Nephew KP; Huang TH; Lai HC; Chan MW
    Lab Invest; 2010 Mar; 90(3):414-25. PubMed ID: 20065949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.
    Hua CD; Bian EB; Chen EF; Yang ZH; Tang F; Wang HL; Zhao B
    Biomed Pharmacother; 2018 Oct; 106():678-685. PubMed ID: 29990858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development.
    Sahu SK; Tiwari N; Pataskar A; Zhuang Y; Borisova M; Diken M; Strand S; Beli P; Tiwari VK
    Nat Commun; 2017 Nov; 8(1):1523. PubMed ID: 29142217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development.
    Chen Z; Ren D; Lv J; Xu Y; Xie M; He X; Shi W; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Ma J; Liu W; Liu S; Ji J
    Cell Signal; 2023 Jul; 107():110677. PubMed ID: 37028779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1.
    Zhang N; Gao X; Yuan Q; Fu X; Wang P; Cai F; Liu H; Zhang J; Liang H; Nie Y; Deng J
    Clin Epigenetics; 2023 May; 15(1):77. PubMed ID: 37147733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis.
    Liao X; Li Z; Zheng H; Qian W; Zhang S; Chen S; Li X; Tang M; Xu Y; Yu R; Li M; Song L; Li J
    Mol Cancer Res; 2023 Jul; 21(7):648-663. PubMed ID: 36961398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
    Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
    Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.
    Mei Z; Zhang D; Hu B; Wang J; Shen X; Xiao W
    J Biol Chem; 2015 Jun; 290(26):16202-14. PubMed ID: 25944903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.
    Habel N; El-Hachem N; Soysouvanh F; Hadhiri-Bzioueche H; Giuliano S; Nguyen S; Horák P; Gay AS; Debayle D; Nottet N; Béranger G; Paillerets BB; Bertolotto C; Ballotti R
    Cell Death Differ; 2021 Jun; 28(6):1837-1848. PubMed ID: 33462405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer.
    Zhang N; Liao Y; Lv W; Zhu S; Qiu Y; Chen N; Xiao M; Zhang H
    Cell Oncol (Dordr); 2022 Apr; 45(2):293-307. PubMed ID: 35411430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT1 Mediated CAHM Repression Promotes Glioma Invasion via SPAK/JNK Pathway.
    Xu Y; Li Z; Huai T; Huo X; Wang H; Bian E; Zhao B
    Cell Mol Neurobiol; 2022 Nov; 42(8):2643-2653. PubMed ID: 34227028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.
    Zhou W; Wei W; Sun Y
    Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.
    Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S
    J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box
    Zhang H; Xia P; Yang Z; Liu J; Zhu Y; Huang Z; Zhang Z; Yuan Y
    Clin Transl Med; 2023 Oct; 13(10):e1443. PubMed ID: 37837399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
    Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
    Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.